Benefits of Attending & Past Statistics
Industry Benefits of Supporting ESID 2026:
- Promotes cutting-edge scientific research
- Contributes to the advancement of Primary Immunodeficiency (PID) on an international level
- Offers a unique opportunity to exchange ideas with renowned professionals from across the world
- Provides an ideal networking forum
- Offers unique exposure to worldwide markets
ESID Attendance over the years
Statistics from ESID 2024 – France, Marseille
Total Registrations
Total Countries
Total Participants In-Person
Total Participants Online
PARTICIPANTS BY WORLD REGIONS
TOP 10 COUNTRIES
0
FRANCE
0
UNITED KINGDOM
0
ITALY
0
GERMANY
0
SPAIN
0
UNITED STATES
0
TURKEY
0
NETHERLANDS
0
SWITZERLAND
0
BELGIUM
PARTICIPANTS BY PROFESSIONAL ROLE
Clinician Practitioner
Clinician Researcher
Other
Basic Science Researcher
Resident/Research Fellow
Industry/ Corporate Professional
Student
Nurse/Healthcare Practitioner
PARTICIPANTS BY PROFESSIONAL INTEREST
Immunology
Allergy & Clinical Immunology
Pediatrics
Other
Internal Medicine
Hematology
Molecular Biology
Pharmacology
Biochemistry
Rheumatology
PARTICIPANTS BY AGE
0%
18 - 30
0%
30 - 40
0%
40 - 50
0%
50 - 60
0%
60+